Merck Stock Holds Steady as Broader Market Declines
Merck & Co.'s stock closed virtually unchanged on September 9, 2026, at USD 148.52 on the Nasdaq after a flat close. This was despite the broader market declining, with the Dow Jones Industrial Average falling about 0.8% and the S&P 500 slipping roughly 0.5%. Merck's stock held steady compared to these benchmarks.
According to Finanzen, the company's shares were nearly unchanged in New York trading that afternoon, consistent with the flat close. This stability is a testament to the continued analyst confidence in the stock, as seen with Leerink Partners reiterating an outperform rating on Merck and raising its price target to USD 161.
Merck's participation in the Wells Fargo 21st Annual Healthcare Conference has been generating interest among investors. The company outlined an expanded growth strategy at the event, which could influence sentiment on Merck & Co. stock as trading resumes today.